Invicta Diagnostic Limited (NSE:INVICTA)
74.75
-2.25 (-2.92%)
At close: Nov 20, 2026
| Market Cap | 939.75M |
| Revenue (ttm) | 407.15M +9.5% |
| Net Income | 34.32M |
| EPS | 2.86 |
| Shares Out | 12.57M |
| PE Ratio | 26.10 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,800 |
| Open | 76.00 |
| Previous Close | 77.00 |
| Day's Range | 72.55 - 76.70 |
| 52-Week Range | 58.10 - 105.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 26, 2026 |